Don Bailey
Director/Board Member chez LINEAGE CELL THERAPEUTICS, INC.
Fortune : 235 025 $ au 31/03/2024
Profil
Don Matthew Bailey is currently the Director at Chapman University and the Director-Applied Innovation Institute at the University of California, Irvine.
He is also an Independent Director at Lineage Cell Therapeutics, Inc. and an Advisor at Cove Management LLC.
In his former positions, Mr. Bailey served as the President, Chief Executive Officer & Director at Questcor Pharmaceuticals, Inc. from 2007 to 2014.
He was also the Chairman at Comarco, Inc. from 2000 to 2007.
Additionally, he held the role of Non-Executive Chairman at Asterias Biotherapeutics, Inc. from 2016 to 2019.
Mr. Bailey was an Independent Director at STAAR Surgical Co. in 2014, Mallinckrodt Plc from 2015 to 2016, Biotie Therapies Oy from 2015 to 2016, and OncoCyte Corp.
from 2016 to 2017.
He also served as a Director at Canon STAAR Co., Inc.Mr. Bailey's education includes a graduate degree from the University of Southern California in 1971, an undergraduate degree from Drexel University in 1968, and an MBA from Pepperdine University in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/02/2024 | 158 801 ( 0,08% ) | 235 025 $ | 31/03/2024 |
Postes actifs de Don Bailey
| Sociétés | Poste | Début |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 |
| Chapman University | Director/Board Member | - |
| University of California, Irvine | Corporate Officer/Principal | - |
Cove Management LLC
 Cove Management LLC Investment ManagersFinance Cove Management LLC (Cove Fund) is a venture capital firm founded in 2014. The firm is headquartered in Irvine, California. | Consultant / Advisor | - |
Anciens postes connus de Don Bailey
| Sociétés | Poste | Fin |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Chairman | 08/03/2019 |
| ONCOCYTE CORPORATION | Director/Board Member | 18/11/2017 |
| BIOTIE THERAPIES CORP | Director/Board Member | 01/05/2016 |
| MALLINCKRODT PLC | Director/Board Member | 01/03/2016 |
| QUESTCOR PHARMACEUTICALS INC | Chief Executive Officer | 14/08/2014 |
Formation de Don Bailey
| University of Southern California | Graduate Degree |
| Drexel University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| STAAR SURGICAL COMPANY | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Comarco, Inc.
 Comarco, Inc. Wireless TelecommunicationsCommunications Comarco, Inc. engaged in the development of technologies in the field of power adapters and chargers for portable mobile devices, which included laptop computers and tablets smartphones. The company was founded in 1960 and was headquartered in Laguna Niguel, CA. | Communications |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
| Canon STAAR Co., Inc. | Health Technology |
Cove Management LLC
Cove Management LLC Investment ManagersFinance Cove Management LLC (Cove Fund) is a venture capital firm founded in 2014. The firm is headquartered in Irvine, California. | Finance |
